false
0001849380
0001849380
2026-07-24
2026-07-24
0001849380
ONMD:CommonStock0.0001ParValuePerShareMember
2026-07-24
2026-07-24
0001849380
ONMD:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember
2026-07-24
2026-07-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 24, 2026
ONEMEDNET
CORPORATION
(Exact
name of Registrant as Specified in Its Charter)
| Delaware |
|
001-40386 |
|
86-2076743 |
(State
or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
6385 Old Shady Oak Road, Suite 250
Eden Prairie, MN 55344
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, Including Area Code: 800-918-7189
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, $0.0001 par value per share |
|
ONMD |
|
The
Nasdaq Stock Market LLC |
| |
|
|
|
|
| Redeemable
Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share |
|
ONMDW |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
5.08 Shareholder Director Nominations.
To
the extent applicable, the information set forth below under Item 8.01 of this Current Report on Form 8-K is incorporated by reference
into this Item 5.08.
Item
8.01 Other Events.
The
Board of Directors of OneMedNet Corporation (the “Company”) has established September 18, 2026 as the date of the Company’s
2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). The record date for stockholders entitled to notice of and
to vote at the 2026 Annual Meeting will be August 11, 2026. Additional details regarding the 2026 Annual Meeting, including the matters
to be considered and voted upon at the 2026 Annual Meeting, will be set forth in the Company’s definitive proxy statement for the
2026 Annual Meeting to be filed with the Securities and Exchange Commission (the “SEC”).
Because
the 2026 Annual Meeting date has been changed by more than 30 calendar days from the anniversary date of the 2025 annual meeting held
on December 17, 2025 (the “2025 Annual Meeting”), pursuant to SEC Rule 14a-8 under the Securities Exchange Act of 1934, as
amended, and the Bylaws of the Company (the “Bylaws”), the deadlines for stockholder nominations and proposals for consideration
at the 2026 Annual Meeting set forth in the Company’s 2025 Annual Meeting proxy statement have been updated as set forth herein.
Proposals
by stockholders intended to be presented at the 2026 Annual Meeting must be received by the Secretary of the Company no later than August
5, 2026, to be eligible for inclusion in the Company’s proxy materials relating to the 2026 Annual Meeting. The Company
has determined that this date is a reasonable time before it expects to begin to print and send its proxy materials for the 2026 Annual
Meeting in accordance with Rule 14a-8(e). The Company will not be required to include in its proxy, notice of meeting or proxy statement
a stockholder proposal that is received after that date or that otherwise fails to meet the requirements for stockholder proposals established
by applicable SEC rules and the Bylaws. Any stockholder who intends to submit a proposal other than for inclusion in the Company’s
proxy materials for the 2026 Annual Meeting must deliver such proposal to the Secretary of the Company no later than August 5,
2026.
Any
proposals by stockholders intended to be presented at the 2026 Annual Meeting, and any notices of intent to solicit proxies for the 2026
Annual Meeting, should be mailed or delivered to OneMedNet Corporation, 6385 Old Shady Oak Road, Suite 250, Eden Prairie, Minnesota 55344,
Attention: Secretary. Such proposals must also comply with all other requirements set forth in the Bylaws and other applicable laws.
As
set forth in the 2025 Annual Meeting proxy statement and as provided in the Bylaws, all stockholder nominations of candidates for election
as directors of the Company must be received by the Secretary of the Company no later than August 5, 2026. Additionally, pursuant
to SEC Rule 14a-19, a stockholder intending to engage in a director election contest with respect to the 2026 Annual Meeting must give
the Company notice of its intent to solicit proxies by providing the name(s) of the stockholder’s nominee(s) and certain other
information by August 5, 2026. All stockholder nominations must be made in writing and delivered or mailed to the Secretary of
the Company at the Company’s principal executive offices located at 6385 Old Shady Oak Road, Suite 250, Eden Prairie, Minnesota
55344.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
July 24, 2026
| |
ONEMEDNET
CORPORATION |
| |
|
|
| |
By: |
/s/
Aaron Green |
| |
|
Aaron Green |
| |
|
Chief Executive Officer |